Background: The CyberKnife © system combines real-time image guidance and a dynamic tracking system to implement frameless radiotherapy. This umbrella review is aimed to evaluate the effectiveness and safety of CyberKnife. Methods: A comprehensive search of health technology assessments and systematic reviews was performed among the Embase, PubMed and other grey databases until July 2020. Treatment outcomes were extracted, and the quality of included studies were assessed using AMSTAR-2. Results: Nineteen studies were eligible. CyberKnife not only had a wide range of applications, long overall survival and great local control, but also had a limited toxicity and good cost-effectiveness compared with other radiotherapy equipment. Conclusion: Despite the relatively low quality of the evidence, our findings can still provide a decision reference for policymakers.
Keyphrases
- early stage
- meta analyses
- end stage renal disease
- systematic review
- ejection fraction
- healthcare
- public health
- radiation therapy
- locally advanced
- chronic kidney disease
- deep learning
- prognostic factors
- case control
- oxidative stress
- squamous cell carcinoma
- quality improvement
- randomized controlled trial
- small cell lung cancer
- risk assessment
- multiple sclerosis
- brain metastases
- social media
- health promotion